Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: Persimmon to replace outbound FTSE 100 constituent Dechra

Fri, 12th Jan 2024 06:59

Persimmon PLC - York, England-based housebuilder - To rejoin FTSE 100 index on Tuesday as acquisition of Cheshire, England-based veterinary drug maker Dechra Pharmaceuticals PLC edges closer. Baillie Gifford US Growth Trust PLC will be added to the FTSE 250 index. The Dechra offers values the firm at around GBP4.5 billion.

Persimmon current stock price: 1,446.00 pence

12-month change: up 3.0%

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
13 Jun 2024 17:01

LONDON MARKET CLOSE: Europe slumps and NY mixed after Fed hold

(Alliance News) - Stocks in Europe fell on Thursday, though shares in New York showed a bit more resilience in the face of a Federal Reserve US intere...

13 Jun 2024 16:34

UK housebuilders bemoan lack of new election housing pledges

June 13 (Reuters) - Britain's housebuilders are disappointed with what they see as a lack of radical measures to tackle the country's housing shorta...

13 Jun 2024 16:15

UK dividends calendar - next 7 days

11 Jun 2024 12:28

UK Conservatives promise to build 1.6 million homes in 5 years

SILVERSTONE, England, June 11 (Reuters) - Britain's governing Conservatives on Tuesday promised voters they would build 1.6 million homes over the n...

11 Jun 2024 11:58

UK's Conservatives promise to build 1.6 million homes

SILVERSTONE, England, June 11 (Reuters) - Britain's governing Conservatives promised voters they would build 1.6 million "well-designed" homes, as the...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.